List of Excipients in API rifapentine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing rifapentine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
sanofi-aventis US LLC | PRIFTIN | rifapentine | 0088-2102 | ALUMINUM OXIDE | |
sanofi-aventis US LLC | PRIFTIN | rifapentine | 0088-2102 | CALCIUM STEARATE | |
sanofi-aventis US LLC | PRIFTIN | rifapentine | 0088-2102 | CELLULOSE, MICROCRYSTALLINE | |
sanofi-aventis US LLC | PRIFTIN | rifapentine | 0088-2102 | EDETATE DISODIUM | |
sanofi-aventis US LLC | PRIFTIN | rifapentine | 0088-2102 | FD&C BLUE NO. 2 | |
sanofi-aventis US LLC | PRIFTIN | rifapentine | 0088-2102 | FERRIC OXIDE RED | |
sanofi-aventis US LLC | PRIFTIN | rifapentine | 0088-2102 | HYDROXYPROPYL CELLULOSE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for rifapentine
Excipient focus: ALUMINUM OXIDE
rifapentine drug variants containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CALCIUM STEARATE
rifapentine drug variants containing CALCIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing CALCIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
rifapentine drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
rifapentine drug variants containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
rifapentine drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
rifapentine drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
rifapentine drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
rifapentine drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
rifapentine drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
rifapentine drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ASCORBATE
rifapentine drug variants containing SODIUM ASCORBATE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing SODIUM ASCORBATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
rifapentine drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
rifapentine drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
rifapentine drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
rifapentine drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
sanofi-aventis US LLC | rifapentine | 0088-2102 |
A-S Medication Solutions | rifapentine | 50090-5063 |
RPK Pharmaceuticals Inc | rifapentine | 53002-1718 |
>Company | >Ingredient | >NDC |
rifapentine drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.